Publishing in the COVID Era.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. New thematic calls for science atResearch and practice in thrombosis and haemostasis · 2022
   Article
2. Goodbye 2020, hello to our future.Research and practice in thrombosis and haemostasis · 2021
   Article
3. The delights and perils of publishing, knowledge-sharing and critique during a pandemic: Observations from COVID-19 coagulopathies.Thrombosis research · 2020
   Article
4. Gender gap in women authors is not worse during COVID-19 pandemic: Results fromResearch and practice in thrombosis and haemostasis · 2020
   Article

Corrections and comments

• Commented on by
  The delights and perils of publishing, knowledge-sharing and critique during a pandemic: Observations from COVID-19 coagulopathies.2020

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.